Skip to main content
. 2019 Mar 22;13:941–948. doi: 10.2147/DDDT.S188171

Figure 1.

Figure 1

Phase 1 crossover study design for pharmacokinetic comparison of BAY 81–8973 vs rFVIII-FS and rAHF-PFM.

Note: rFVIII-FS and rAHF-PFM were used as comparators in separate phase 1 studies.

Abbreviations: rAHF-PFM, antihemophilic factor (recombinant) plasma/albumin-free method; rFVIII-FS, sucrose-formulated recombinant factor VIII.